ALBANY, New York, November 3, 2016 /PRNewswire/ -- The global market for dental membrane and bone graft substitutes is rather fragmented, with the top four companies accounting for 30.0% in 2015. DENTSPLY International, Inc., Zimmer Biomet Holdings, Inc., Institute Straumann AG, and Integra LifeSciences Holdings Corporation presently dominate the global scene. Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the Dental Membrane and Bone Graft Substitutes Market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to rise from a value of US$419 mn in 2015 to US$922.6 mn by 2024. If these values hold true, the market is expected to exhibit a strong CAGR of 9.3% during the forecast period. Bone Graft Substitutes Enjoy Dominance over Dental Membranes Bone graft substitutes formed the leading product segment, accounting for a whopping 94.8% market share in 2015. Xenograft was the dominant sub-segment in 2015. Dental membranes, however, are expected to register a CAGR of 10.1% from 2016 to 2024, emerging as a highly lucrative investment option. By material, human cells sources hold the dominant share, while collagen is projected to witness strong growth in the near future. Dental clinics are the leading as well as most promising end users of dental membranes and bone graft substitutes. Europe held the major share of 27.8% in the dental membrane and bone graft substitutes market in 2016. Asia Pacific, on the other hand, is projected to be a rapidly growing market, registering a CAGR of 11.0% from 2016 to 2024. Download PDF Brochure of Research Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16340Increasing Dental Tourism in Developing Countries Spurs Growth The rapid growth of dental tourism across developing countries such as Hungary, Mexico, China, and India has resulted in the availability of cost-effective and quality dental services. Healthy Travel Media, a leading publishing house in the U.S., finds that developing nations offer dental services at a cost that is 50% to 80% lower than that in developed countries such as the U.S. This has resulted in a surge in dental procedures across the globe, thereby fueling the demand for dental membranes and bone graft substitutes. "Innovation in bone graft techniques is also a key factor driving this market," the author of the study says. Advanced techniques such as xenograft and demineralized bone matrix have gained preference among patients in recent times owing to the several benefits they offer. Bone grafting is a procedure performed to replace a missing bone in a patient. Ideally, bone grafts are autologous, which means that the bone is harvested from the patient's own body. This can be an extremely complex and risky procedure. Moreover, there is an acute shortage of donors. The development of xenografts allows bone substitutes to be taken from non-human species, such as bovine or natural coral, which addresses this shortage and also serves as a preferred options for people suffering from heart and kidney ailments.